-
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS TrialsM Konigstein, PC Smits, MP Love et al. -
Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trialM Mancone, R Cavalcante, PW Serruys et al.
-
Large-Bore Radial Access for Complex PCI: A Flash of COLOR With Some Shades of GreyM Valgimigli, A Landi et al.
-
Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art ReviewLA Sposato , MJ Hilz , S Aspberg et al.
-
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyCT January, LS Wann, H Calkins et al.
-
Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of MorbidityKhan SS, Ning H, Wilkins JT et al.
-
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 YearsRA Buiten, EH Ploumen, P Zocca et al.
-
Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunctionF Leuschner, M Nahrendorf et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
